Your session is about to expire
← Back to Search
SVC Assessment for POTS
Study Summary
This trial found that meals rich in carbohydrates worsened the symptoms of POTS by causing excessive blood pooling in the splanchnic circulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have rheumatoid arthritis.I regularly use acetaminophen.I am between 18 and 50 years old.I am a pre-menopausal woman with a regular menstrual cycle.I am taking statins for high cholesterol.My liver isn't working properly.I have a history of heart issues like heart attack or stroke.I have had surgery on my neck.Your medical records show a significant decrease in blood volume.I have diabetes (type 1 or type 2).You have an abnormal EKG (electrocardiogram).Your body mass index (BMI) is between 18.5 and 29.9.My kidney function is not normal.Your body mass index (BMI) is between 18.5 and 29.9.I have been diagnosed with neuropathy.I have been diagnosed with POTS and feel faint after eating.I have POTS and feel faint after eating or I'm healthy, don't smoke, and take no regular meds.I do not have any current infections.You cannot tolerate using a CPAP machine.I am a pre-menopausal woman with a regular menstrual cycle.I have had seizures in the past.I am currently taking oral corticosteroids.You smoke cigarettes.Your weight compared to your height is within a certain range.My blood pressure is not controlled by medication.You are currently using drugs or alcohol excessively.You have a body mass index (BMI) higher than 30 kg/m2.Your periods don't come regularly.You have no major health problems, do not smoke, and are not taking long-term medications.Your blood does not have enough red cells (Hematocrit<34%).I am between 18 and 50 years old.
- Group 1: Splanchnic venous capacitance(SVC).
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the participant demographic restricted to individuals 18 years or older?
"This clinical investigation will include patients between 18 years old and 50 years of age."
May I submit an application to join this investigation?
"The requirements for acceptance into this study are a diagnosis of tachycardia and age between 18 to 50. In total, the trial is seeking 50 participants."
Are there any slots available for those wishing to participate in this experiment?
"The information found on clinicaltrials.gov states that this particular medical trial is not actively recruiting at present, having been first posted on November 20th 2022 and last amended on the 6th of November. However, 1483 other research efforts are currently in search for patients to participate."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger